A child with eczema has been treated unsuccessfully with a topical glucocorticoid for a year and now has skin atrophy and hypopigmentation. What change in therapy will the provider recommend to the parents?

Question

Quizplus · Accepted Answer

Topical immunosuppressants, such as tacrolimus or pimecrolimus, are often recommended when there is a need to avoid the side effects of long-term topical glucocorticoid use, such as skin atrophy and hypopigmentation. These agents work by suppressing the immune response in the skin, thereby reducing inflammation and itching without the adverse effects associated with prolonged steroid use.

A Child with Eczema Has Been Treated Unsuccessfully with a Topical